![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, December 15, 2015 11:28:58 AM
Our question is can they even do a trial?
Do they have the financials to support a trail of whatever design?
Big difference in a Phase 1 and a Phase 3 trial.
Here is another question. During all this FDA waiting time. Do they even have a trial developed at this point that can be started in the coming months. Do they even have any trial sites considered or a trial subject population to target for a trial. How many sites? How many do they want to enroll in the study? When would they even aticipate the start date pending closing the enrolement period to have all the necessary subjects.
Take a look at NVAX who just today annouced the competing of an enrolment period of their study that is to begin shortly. Its a very large study of over 11 thousand enrolled.
GL
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM